CORRECT ALGORITHM OF ARVI TREATMENT IN PEDIATRIC PATIENTS
Acute respiratory infections (ARI) occupy the first place in morbidity among children and among adults for the past many decades. In General, the treatment is assigned to doctors on the basis of examination of the patient, in the absence of laboratory data on etiological characteristics of the infec...
Main Authors: | N. G. Kolosova, S. I. Shatalina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2207 |
Similar Items
-
An improvement of the child acute respiratory infection treatment program
by: E. N. Simovan'yan, et al.
Published: (2013-01-01) -
Current trends in the treatment of ARVI: how to avoid polypharmacy?
by: E. V. Obraztsova, et al.
Published: (2015-12-01) -
Issues of treatment and prevention of recurrent inflammatory diseases of the upper respiratory tract: An immunologist's view. A review
by: Andrei E. Shul'zhenko, et al.
Published: (2024-12-01) -
IMMUNITY DYSFUNCTION IN RESPIRATORY DISEASES: DO FREQUENTLY ILL CHILDREN NEED IMMUNOMODULATORS?
by: A. V. Karaulov
Published: (2015-04-01) -
Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study
by: Jiří Beran, et al.
Published: (2016-11-01)